Vasoactive Intestinal Peptide
Showing 1 - 25 of 5,817
Sepsis, Respiratory Distress Syndrome, Respiratory Distress Syndrome, Adult Trial in Northport, Stony Brook (vasoactive
Completed
- Sepsis
- +2 more
- vasoactive intestinal peptide
-
Northport, New York
- +1 more
May 3, 2022
Migraine, Pain, Neurologic Manifestations Trial in Glostrup (Vasoactive Intestinal Polypeptide (VIP), Sterile saline)
Completed
- Migraine
- +5 more
- Vasoactive Intestinal Polypeptide (VIP)
- Sterile saline
-
Glostrup, Copenhagen, DenmarkDanish Headache Center
Oct 19, 2020
Headache Disorders Trial in København S (Vasoactive Intestinal Peptide (VIP) and Saline)
Completed
- Headache Disorders
- Vasoactive Intestinal Peptide (VIP) and Saline
-
København S, Danmark, DenmarkDanish headache center
Aug 19, 2020
Critical COVID-19 With Respiratory Failure Trial in United States (ZYESAMI (aviptadil acetate))
No longer available
- Critical COVID-19 With Respiratory Failure
- ZYESAMI (aviptadil acetate)
-
Gilbert, Arizona
- +24 more
Jul 19, 2022
Pulmonary Arterial Hypertension Trial in United States (Pemziviptadil (PB1046))
Terminated
- Pulmonary Arterial Hypertension
- Pemziviptadil (PB1046)
-
Mobile, Alabama
- +25 more
Feb 4, 2022
SARS-CoV 2, COVID, ARDS Trial (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or Placebo)
Withdrawn
- SARS-CoV 2
- +5 more
- ZYESAMI™ (aviptadil acetate)
- +2 more
- (no location specified)
Feb 2, 2023
Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine
Not yet recruiting
- Digestive System Neuroendocrine Tumor G1
- +5 more
- Tumor Debulking
- +5 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Aug 23, 2023
SARS-CoV 2, COVID, ARDS Trial in United States (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or
Terminated
- SARS-CoV 2
- +5 more
- ZYESAMI™ (aviptadil acetate)
- +2 more
-
Fullerton, California
- +12 more
Feb 2, 2023
Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)
Completed
- Covid19
- Remdesivir
- +4 more
-
Tucson, Arizona
- +39 more
Dec 16, 2022
Pulmonary Arterial Hypertension Trial in Columbus, Pittsburgh (PB1046 Subcutaneous Injection)
Completed
- Pulmonary Arterial Hypertension
- PB1046 Subcutaneous Injection
-
Columbus, Ohio
- +1 more
Oct 7, 2019
Trigeminal Neuralgia Trial (trigminal nerve block with RFT)
Not yet recruiting
- Trigeminal Neuralgia
- trigminal nerve block with RFT
- (no location specified)
Jan 29, 2023
Transcutaneous Electrical Acupoint Stimulation Trial (transcutaneous electrical acupoint stimulation)
Not yet recruiting
- Transcutaneous Electrical Acupoint Stimulation
- transcutaneous electrical acupoint stimulation
- (no location specified)
May 17, 2022
Blood Flow Trial in Copenhagen (GIPR antagonist / study tool, GLP-2R antagonist / study tool, Placebo)
Recruiting
- Blood Flow
- GIPR antagonist / study tool
- +2 more
-
Copenhagen, DenmarkRigshospitalet
Nov 2, 2022
Patients With Polycystic Ovary Syndrome (PCOS)
Recruiting
- Polycystic Ovary Syndrome
- Ovary Biopsie
-
Tirana, AlbaniaUniversity of medicine of Tirana
Jul 28, 2023
Gastroenteropancreatic Neuroendocrine Tumor Trial in Stanford (Lutathera, Gallium 68 Dotatate, Computed Tomography (CT))
Suspended
- Gastroenteropancreatic Neuroendocrine Tumor
- Lutathera
- +4 more
-
Stanford, CaliforniaStanford Cancer Institute Palo Alto
Sep 21, 2022
Critical COVID-19 With Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS), Corona Virus Infection Trial in United
Completed
- Critical COVID-19 With Respiratory Failure
- +3 more
- Aviptadil by intravenous infusion + standard of care
- Normal Saline Infusion + standard of care
-
Fullerton, California
- +9 more
Sep 5, 2021
Neuropeptides and Venous Pelvic Pain
Active, not recruiting
- Pelvic Pain
- +2 more
-
Moscow, Russian FederationDepartment of Faculty Surgery №1
Sep 20, 2021
Sars-CoV-2 Infection Trial in São Paulo, Guarulhos (Analysis of genetic polymorphisms of vasoactive peptides in COVID-19)
Not yet recruiting
- Sars-CoV-2 Infection
- Analysis of genetic polymorphisms of vasoactive peptides in COVID-19
-
São Paulo, Sao Paulo, Brazil
- +1 more
Dec 14, 2021
Type 2 Diabetes, Obesity Trial in Turku (Roux-en-Y, GIP-infusion, GLP-1)
Completed
- Type 2 Diabetes
- Obesity
- Roux-en-Y
- +4 more
-
Turku, FinlandTurku univercity hospital, PET center
Oct 12, 2021
Seasonal Allergic Rhinitis Trial in Beijing (SPA acupuncture, sham acupuncture)
Recruiting
- Seasonal Allergic Rhinitis
- SPA acupuncture
- sham acupuncture
-
Beijing, Beijing, ChinaHongfei Lou
Aug 19, 2022
Postural Tachycardia Syndrome (POTS) Trial in Nashville (Measurement of Splanchnic venous capacitance(SVC))
Not yet recruiting
- Postural Tachycardia Syndrome (POTS)
- Measurement of Splanchnic venous capacitance(SVC)
-
Nashville, TennesseeVanderbilt University Medical Center
Dec 8, 2022
Cerebral Palsy Trial in Amersham, Brighton, Manchester (Paediatric Formula)
Completed
- Cerebral Palsy
- Paediatric Formula
-
Amersham, United Kingdom
- +2 more
Aug 17, 2020
New Persistent Daily Headache Trial (CGRP antibody)
Not yet recruiting
- New Persistent Daily Headache
- CGRP antibody
- (no location specified)
Aug 29, 2023
Allergic Rhinitis Trial in Beijing (AIT drops, Clarityne, Rhinocort and Emedastine Difumarate Eye Drops)
Recruiting
- Allergic Rhinitis
- AIT drops
- Clarityne, Rhinocort and Emedastine Difumarate Eye Drops
-
Beijing, China
- +2 more
May 21, 2022